science
Johnson & Johnson to Offer Xarelto, Invokana and Metformin Through Discount Drug Program
Johnson & Johnson announced it will offer three drugs through the TrumpRx program. The move includes Xarelto, Invokana and metformin, aimed at expanding discounted drug access. Seekingalpha.com reported the development as part of broader efforts to improve medication affordability.
Apr 24, 5:37 PM·1m read1 source
benzinga.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
Com reported. The pharmaceutical company plans to distribute the blood thinner Xarelto through the program, which focuses on providing lower-cost medications to eligible patients. Johnson & Johnson will also sell the diabetes drug Invokana via TrumpRx, adding to the initiative's offerings for chronic condition treatments.
Additionally, the company will provide metformin, another diabetes medication, through TrumpRx, further broadening access to discounted drugs for those in need.
Transparency
How sources framed this
Single source — no framing comparison available.
CorroborationLimited · 1 source
